Fuzhen Wan1, Feng Pan1, Oyekoya Ayonrinde2,3,4, Leon A Adams2,5, Trevor A Mori2, Lawrence J Beilin2, Therese A O'Sullivan6, John K Olynyk3,6, Wendy H Oddy7. 1. Nutritional Epidemiology, Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, TAS, 7000, Australia. 2. Medical School, The University of Western Australia, Perth, WA, Australia. 3. Department of Gastroenterology and Hepatology, Fiona Stanley Hospital, Murdoch University, Perth, WA, Australia. 4. Faculty of Health Sciences, Curtin University, Perth, WA, Australia. 5. Department of Hepatology, Sir Charles Gairdner Hospital, Perth, WA, Australia. 6. School of Medical and Health Science, Edith Cowan University, Perth, WA, Australia. 7. Nutritional Epidemiology, Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, TAS, 7000, Australia. Wendy.Oddy@utas.edu.au.
Abstract
BACKGROUND AND AIM: Dietary fat intake has long been associated with fatty liver. Our study aimed to determine the effect of dietary fats on longitudinal fatty liver index (FLI) trajectories from adolescence to young adulthood. METHODS: Nine hundred eighty-five participants in the Raine Study, Perth, Western Australia, Australia, had cross-sectional assessments at ages 14, 17, 20 and 22 years, during which anthropometric measurements and blood tests were obtained. FLI trajectories were derived from the longitudinal FLI results. Dietary fat intake was measured with a semi-quantitative food frequency questionnaire at 14 years and log multinominal regression analyses were used to estimate relative risks. RESULTS: Three FLI trajectories were identified and labelled as stable-low (79.1%, N = 782), low-to-high (13.9%, N = 132), and stable-high (7%, N = 71). The low-to-high group associated with an increased intake of the long-chain polyunsaturated fatty acids EPA, DPA and DHA (RR 1.27, 95% CI 1.10-1.48) relative to the stable-low group. Compared to the stable-low group, omega-6 and the ratio of omega-6 to omega-3 in the stable-high group were associated with an increased relative risk of 1.34 (95% CI 1.02-1.76) and 1.10 (95% CI 1.03-1.16), respectively. CONCLUSION: For those at high risk of fatty liver in early adolescence, high omega-6 fatty acid intake and a high ratio of omega-6 to omega-3 fatty acids are associated with increased risk of fatty liver. There should be caution in assuming these associations are causal due to possible undetected and underestimated confounding factors.
BACKGROUND AND AIM: Dietary fat intake has long been associated with fatty liver. Our study aimed to determine the effect of dietary fats on longitudinal fatty liver index (FLI) trajectories from adolescence to young adulthood. METHODS: Nine hundred eighty-five participants in the Raine Study, Perth, Western Australia, Australia, had cross-sectional assessments at ages 14, 17, 20 and 22 years, during which anthropometric measurements and blood tests were obtained. FLI trajectories were derived from the longitudinal FLI results. Dietary fat intake was measured with a semi-quantitative food frequency questionnaire at 14 years and log multinominal regression analyses were used to estimate relative risks. RESULTS: Three FLI trajectories were identified and labelled as stable-low (79.1%, N = 782), low-to-high (13.9%, N = 132), and stable-high (7%, N = 71). The low-to-high group associated with an increased intake of the long-chain polyunsaturated fatty acids EPA, DPA and DHA (RR 1.27, 95% CI 1.10-1.48) relative to the stable-low group. Compared to the stable-low group, omega-6 and the ratio of omega-6 to omega-3 in the stable-high group were associated with an increased relative risk of 1.34 (95% CI 1.02-1.76) and 1.10 (95% CI 1.03-1.16), respectively. CONCLUSION: For those at high risk of fatty liver in early adolescence, high omega-6 fatty acid intake and a high ratio of omega-6 to omega-3 fatty acids are associated with increased risk of fatty liver. There should be caution in assuming these associations are causal due to possible undetected and underestimated confounding factors.
Authors: Cynthia L Ogden; Margaret D Carroll; Hannah G Lawman; Cheryl D Fryar; Deanna Kruszon-Moran; Brian K Kit; Katherine M Flegal Journal: JAMA Date: 2016-06-07 Impact factor: 56.272
Authors: Wendy H Oddy; Carly E Herbison; Peter Jacoby; Gina L Ambrosini; Therese A O'Sullivan; Oyekoya T Ayonrinde; John K Olynyk; Lucinda J Black; Lawrence J Beilin; Trevor A Mori; Beth P Hands; Leon A Adams Journal: Am J Gastroenterol Date: 2013-04-02 Impact factor: 10.864
Authors: Anna Marina; Anize Delfino von Frankenberg; Seda Suvag; Holly S Callahan; Mario Kratz; Todd L Richards; Kristina M Utzschneider Journal: Nutrients Date: 2014-10-28 Impact factor: 5.717
Authors: Sandi L Navarro; Marian L Neuhouser; Ting-Yuan David Cheng; Lesley F Tinker; James M Shikany; Linda Snetselaar; Jessica A Martinez; Ikuko Kato; Shirley A A Beresford; Robert S Chapkin; Johanna W Lampe Journal: Nutrients Date: 2016-11-30 Impact factor: 5.717
Authors: Ju-Sheng Zheng; Stephen J Sharp; Fumiaki Imamura; Albert Koulman; Matthias B Schulze; Zheng Ye; Jules Griffin; Marcela Guevara; José María Huerta; Janine Kröger; Ivonne Sluijs; Antonio Agudo; Aurelio Barricarte; Heiner Boeing; Sandra Colorado-Yohar; Courtney Dow; Miren Dorronsoro; Pia T Dinesen; Guy Fagherazzi; Paul W Franks; Edith J M Feskens; Tilman Kühn; Verena Andrea Katzke; Timothy J Key; Kay-Tee Khaw; Maria Santucci de Magistris; Francesca Romana Mancini; Elena Molina-Portillo; Peter M Nilsson; Anja Olsen; Kim Overvad; Domenico Palli; Jose Ramón Quirós; Olov Rolandsson; Fulvio Ricceri; Annemieke M W Spijkerman; Nadia Slimani; Giovanna Tagliabue; Anne Tjonneland; Rosario Tumino; Yvonne T van der Schouw; Claudia Langenberg; Elio Riboli; Nita G Forouhi; Nicholas J Wareham Journal: BMC Med Date: 2017-11-17 Impact factor: 8.775